Randomized Controlled Clinical Trial to Access Efficacy and Safety of Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil

Miltefosine has been used in the treatment of several new world cutaneous leishmaniasis (CL) species with variable efficacy. Our study is the first evidence on its clinical efficacy in Leishmania (Viannia) guyanensis. In this phase II/III randomized clinical trial, 90 CL patients were randomly alloc...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Chrusciak-Talhari, Anette, Dietze, Reynaldo, Chrusciak Talhari, Carolina, da Silva, Roberto Moreira, Gadelha Yamashita, Ellen Priscila, de Oliveira Penna, Gerson, Lima Machado, Paulo Roberto, Talhari, Sinésio
Formato: Artigo
Idioma:Inglês
Publicado: The American Society of Tropical Medicine and Hygiene 2011
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3029178/
https://ncbi.nlm.nih.gov/pubmed/21292895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.2011.10-0155
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares